Clinical Research at The Liver Institute at Methodist Dallas
An active program in clinical research continues to grow in both local and national recognition and enhances patient care at The Liver Institute.
The Liver Institute at Methodist Dallas is currently involved in several research projects regarding treatments for patients with chronic hepatitis C, hepatitis B, and other liver diseases.
In August 2011, The Liver Institute announced it is involved in several clinical trials using a newer generation of drugs for the treatment of chronic hepatitis C. The trials will focus on a second generation of direct-acting antiviral drugs for hepatitis C that are very potent and may shorten the duration of therapy in a number of patients. These antiviral drugs offer very promising hope for eradication of hepatitis C for patients who have experienced and failed treatment in the past.
Read Liver Transplantation for Hepatocellular Carcinoma (HCC) from the book Liver Transplantation - Basic Issues by Dr. Alejandro Mejia, Dr. Hector Nazario, and Dr. Parvez Mantry.
The Liver Institute at Methodist Dallas is a major tertiary referral center for North Texas and the surrounding regions. Independently practicing physicians at The Liver Institute at Methodist Dallas are available to meet the needs of both referring physicians and patients alike.
Texas law prohibits hospitals from practicing medicine. The physicians on the Methodist Health System medical staff, including those practicing at The Liver Institute at Methodist Dallas Medical Center and the Methodist Dallas Transplant Institute, are independent practitioners who are not employees or agents of Methodist Health System or any other affiliated institution.
The contents of this site are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician or other health care provider regarding any medical conditions or decisions about medical care.